Effect [qlco]
Long-term [tmco]
Hormone replacement therapy [topp]
angiotensin converting enzyme activity [moft]
Bradykinin [aapp, horm, nsba]
postmenopausal [tmco]
Women [popg]
Essential Hypertension [dsyn]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
Objective [inpr]
Hormone replacement therapy [topp]
Incidence [qnco]
Cardiovascular disease [dsyn]
postmenopausal [tmco]
Women [popg]
Three [qnco]
month [tmco]
Short-term [tmco]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Essential Hypertension [dsyn]
Increased [qnco]
plasma concentration [qnco]
Bradykinin [aapp, horm, nsba]
Decreased [qnco]
Serum [bdsu]
angiotensin converting enzyme activity [moft]
Responsible [fndg]
effects [qlco]
Hormone replacement therapy [topp]
Objective [inpr]
To [qlco]
month [tmco]
Long-term [tmco]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Essential Hypertension [dsyn]
Maintain [acty]
Decreased [qnco]
angiotensin converting enzyme activity [moft]
Increased [qnco]
Bradykinin [aapp, horm, nsba]
Levels [qlco]
Long-term [tmco]
Hormone replacement therapy [topp]
Increase [ftcn]
plasma concentration [qnco]
Bradykinin [aapp, horm, nsba]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
Show [inpr]
month [tmco]
Hormone replacement therapy [topp]
Study [mnob]
Decreased [qnco]
Serum [bdsu]
angiotensin converting enzyme activity [moft]
Design [acty]
twenty [orch, phsu]
hypertensive [fndg]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
treated [topp]
Estrogens, Conjugated [horm, phsu, strd]
mg day [qnco]
Medroxyprogesterone [horm, phsu, strd]
mg day [qnco]
months [tmco]
twenty [orch, phsu]
hypertensive [fndg]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
Control [grup]
Control [grup]
Not [ftcn]
treated [topp]
Hormone replacement therapy [topp]
Serum [bdsu]
angiotensin converting enzyme activity [moft]
plasma concentration [qnco]
Bradykinin [aapp, horm, nsba]
Measured [qlco]
baseline [bodm]
months [tmco]
Result [ftcn]
Long-term [tmco]
Hormone replacement therapy [topp]
hypertensive [fndg]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
Decreased [qnco]
Serum [bdsu]
angiotensin converting enzyme activity [moft]
IU/L [qnco]
IU/L [qnco]
baseline [bodm]
IU/L [qnco]
IU/L [qnco]
months [tmco]
Start [tmco]
Hormone replacement therapy [topp]
P NOS [aapp, imft]
P NOS [aapp, imft]
Long-term [tmco]
Hormone replacement therapy [topp]
hypertensive [fndg]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
Increased [qnco]
plasma concentration [qnco]
Bradykinin [aapp, horm, nsba]
pg/mL [qnco]
pg/mL [qnco]
baseline [bodm]
pg/mL [qnco]
pg/mL [qnco]
months [tmco]
Start [tmco]
Hormone replacement therapy [topp]
P NOS [aapp, imft]
P NOS [aapp, imft]
Serum [bdsu]
angiotensin converting enzyme activity [moft]
plasma concentration [qnco]
Bradykinin [aapp, horm, nsba]
Observed [ftcn]
Control Groups [grup]
Conclusions [idcn]
Long-term [tmco]
Hormone replacement therapy [topp]
hypertensive [fndg]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
Decrease [qlco]
Serum [bdsu]
angiotensin converting enzyme activity [moft]
Increase [ftcn]
plasma concentration [qnco]
Bradykinin [aapp, horm, nsba]
Maintenance [acty]
Elevated [qlco]
Bradykinin [aapp, horm, nsba]
Decreased [qnco]
Serum [bdsu]
angiotensin converting enzyme activity [moft]
Hormone replacement therapy [topp]
Reducing [qlco]
Risk [qlco]
Cardiovascular disease [dsyn]
hypertensive [fndg]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
